142 related articles for article (PubMed ID: 37461136)
1. Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm.
Pell J; Nagata S; Menon MC
Kidney360; 2023 Sep; 4(9):e1325-e1331. PubMed ID: 37461136
[TBL] [Abstract][Full Text] [Related]
2. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
[TBL] [Abstract][Full Text] [Related]
3. A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis.
McNulty MT; Fermin D; Eichinger F; Jang D; Kretzler M; Burtt NP; Pollak MR; Flannick J; Weins A; Friedman DJ; ; Sampson MG
Kidney Int; 2022 Jul; 102(1):136-148. PubMed ID: 34929253
[TBL] [Abstract][Full Text] [Related]
4. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
5. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
6. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
7.
Zhang JY; Wang M; Tian L; Genovese G; Yan P; Wilson JG; Thadhani R; Mottl AK; Appel GB; Bick AG; Sampson MG; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3446-3451. PubMed ID: 29531077
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort.
Durand A; Winkler CA; Vince N; Douillard V; Geffard E; Binns-Roemer E; Ng DK; Gourraud PA; Reidy K; Warady B; Furth S; Kopp JB; Kaskel FJ; Limou S
Am J Kidney Dis; 2023 Jun; 81(6):635-646.e1. PubMed ID: 36623684
[TBL] [Abstract][Full Text] [Related]
9. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
10. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease.
Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; Espinoza A; Luo Y; Wei WQ; Feng Q; Weng C; Fang Y; Kullo IJ; Naderian M; Limdi N; Irvin MR; Tiwari H; Mohan S; Rao M; Dube GK; Chaudhary NS; Gutiérrez OM; Judd SE; Cushman M; Lange LA; Lange EM; Bivona DL; Verbitsky M; Winkler CA; Kopp JB; Santoriello D; Batal I; Pinheiro SVB; Oliveira EA; Simoes E Silva AC; Pisani I; Fiaccadori E; Lin F; Gesualdo L; Amoroso A; Ghiggeri GM; D'Agati VD; Magistroni R; Kenny EE; Loos RJF; Montini G; Hildebrandt F; Paul DS; Petrovski S; Goldstein DB; Kretzler M; Gbadegesin R; Gharavi AG; Kiryluk K; Sampson MG; Pollak MR; Sanna-Cherchi S
Nat Commun; 2023 Nov; 14(1):7836. PubMed ID: 38036523
[TBL] [Abstract][Full Text] [Related]
11. APOL1 localization in normal kidney and nondiabetic kidney disease.
Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
[TBL] [Abstract][Full Text] [Related]
12. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
13. Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
Peng T; Li G; Zhong X; Wang L
Ren Fail; 2017 Nov; 39(1):500-504. PubMed ID: 28494221
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
Kopp JB; Winkler CA; Zhao X; Radeva MK; Gassman JJ; D'Agati VD; Nast CC; Wei C; Reiser J; Guay-Woodford LM; Pollak MR; Hildebrandt F; Moxey-Mims M; Gipson DS; Trachtman H; Friedman AL; Kaskel FJ;
J Am Soc Nephrol; 2015 Jun; 26(6):1443-8. PubMed ID: 25573908
[TBL] [Abstract][Full Text] [Related]
15. APOL1 Nephropathy: From Genetics to Clinical Applications.
Friedman DJ; Pollak MR
Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
[TBL] [Abstract][Full Text] [Related]
16.
Friedman DJ; Pollak MR
Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
18. APOL1 high-risk genotypes and renal transplantation.
Shah S; Shapiro R; Murphy B; Menon MC
Clin Transplant; 2019 Jun; 33(6):e13582. PubMed ID: 31050035
[TBL] [Abstract][Full Text] [Related]
19. FSGS and COVID-19 in Non-African American Patients.
Medina E; Rueda C; Batlle D
Kidney360; 2023 May; 4(5):687-699. PubMed ID: 37229730
[TBL] [Abstract][Full Text] [Related]
20. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
Kopp JB; Heymann J; Winkler CA
Semin Nephrol; 2017 Nov; 37(6):514-519. PubMed ID: 29110758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]